If you need more lookups,
subscriptions start at $34 USD/month.
Hye-Won Koo Location
Incheon, South Korea
Hye-Won Koo Work
Senior Medical Director @ (April 2019 - Present)
Director Medical Affairs @ (September 2015 - March 2019)
Senior Research Fellow, NECA and KIDS (Korean Institute of Drug Safety and Management) @ (September 2014 - August 2015)
Medical Director (Korea), Market Access Director(Asia Area) @ (March 2012 - March 2014)
AP Regional Director, Epidemiology and Health-outcomes, Vaccine development @ (September 2010 - February 2012)
Market Access Director, Phamaceuticals @ (June 2006 - August 2010)
Pharmaco-economics and Outcomes research, Associate Director @ MSD Korea (April 2004 - May 2005)
Medical Advisor @ Novartis Korea (September 2004 - March 2005)
Medical Epidemiologist @ (March 2001 - August 2003)
Medical Researcher @ (March 1998 - February 2001)
Residency and Research fellowship @ (March 1994 - February 1998)
Hye-Won Koo Education
Erasmus Universiteit Rotterdam
MSc (Health-economics, policy and law)
2003-2004
Seoul National University, Graude school of Medicine
PhD (Pharmaco-epidemiology)
1997-1999
Inje University, Graduate school of Public Health
MPH (Public Health)
1994-1996
Inje University
MD (Medicine)
1987-1993
Hye-Won Koo Skills
Leadership
Marketing
PowerPoint
Data Analysis
Strategic Planning
Teaching
International Health
Clinical Research
Screenwriting
Cancer
Gate
Hye-Won Koo Summary
Hye-Won Koo, based in Incheon, South Korea, is currently a Senior Medical Director at Astellas korea. Hye-Won Koo brings experience from previous roles at Baxter International Inc., National Evidence-based Healthcare Collaborating Agency (NECA), AstraZeneca and GlaxoSmithKline Biologicals, Asia Pacific. Hye-Won Koo holds a 2003 - 2004 MSc in Health-economics, policy and law @ Erasmus Universiteit Rotterdam. With a robust skill set that includes Leadership, Marketing, PowerPoint, Data Analysis, Strategic Planning and more. Hye-Won Koo has 1 emails on RocketReach.
Looking for a different Hye-Won Koo?
Find contact details for 700 million professionals.